Peer-Reviewed Research and Oncotarget

The dissemination of cutting-edge and important information provides the heart of all biomedical publishing. Scientific journals, like Oncotarget, catalog the studies, contributions, thoughts, and opinions of investigators, researchers, and experts in the biomedical field. This information is essential for students who are pursuing higher degree of education; as well as, medical professionals and researchers endeavoring to further the biomedical research essential to the entire medical process. Check the journal at SCImago Journal & Country Rank.

Oncotarget is a peer-reviewed journal that is focused on the evolving study of oncology and cancer treatment. When the journal was first published in 2010, the goal was to get new and life-saving oncology research into the hands of the medical professionals who could use it. Because of demand for high-quality biomedical journals it now covers several other biomedical areas of study. Oncotarget is now a multidisciplinary journal that covers, in addition to oncology: neuroscience, endocrinology, cardiology, metabolism, cell biology, pharmacology. Oncotarget publishes this collection of papers, online, twice a week. Each issue of paper can be printed on special request so that whenever you need it, the information is available to you. Andrew V. Schally, Nobel Prize in Physiology or Medicine, 1977, said in praise of Oncotarget: Download output styles at Endnote.com

“Oncotarget is an outstanding and most important journal in the field of oncology and cancer research. Oncotarget is performing an extremely useful function for those of us working not only in cancer research, but also on other important topics in the field of medicine. Oncotarget deserves a strong support from investigators working in the area of oncology as well as from NIH.”

This high praise is coming when the demand for Oncotarget is at it’s highest. This is why they made the decision to add the second weekly edition and expanded the subjects they are reviewing. This will allow them to review new research in other fields, as well, and make them available as soon as possible. Peer-review remains the highest standard of academic review. Oncotarget carries on that standard by delivering the newest and best biomedical research to the academic and medical communities.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/

Leave a reply

Your email address will not be published.

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>